News
HVP – Kaleo and the Clinton Foundation’s Health Matters Initiative Unite to Reduce Prescription Opioid-Related Deaths
RICHMOND, Va., Jan. 27, 2015 /PRNewswire/ — Kaleo, a privately-held pharmaceutical company, today announced a national strategic partnership with the Clinton Health Matters Initiative (CHMI), an initiative of the Clinton Foundation, that will help support its goal of cutting prescription drug-related deaths in half, saving approximately 10,000 lives over five years. In partnership with CHMI, kaleo will make EVZIO® (naloxone HCl injection) Auto-Injector, an emergency treatment for opioid overdose, available at a discount to colleges and universities, public safety organizations and community organizations placing this potentially life-saving medicine in the hands of those who can intervene quickly.
To view full article, please click here.